You sir hit the nail on the head. I am a day trader, and there is one stock I sold a good amount of shares of once and decided I was not going to do that again (CYDY back in March) I decided after that day, I'm sticking with CYDY for the 'long haul'. Shorts only give me more opportunity to buy and accumulate shares. All of NP's conference calls and unmet timelines only allow me to accumulate shares at a discount. Those people invested in this stock for the long term, not for a quick profit, should see that the shorts and NP give us very valuable opportunities to load up at a discount. Either the FDA is forced by overwhelming evidence to approve us or they do not. The drug is the same. It has not changed at all since I became an investor. When the price dips it is a golden opportunity for those that truly believe in this company and drug.